25 May 2013
Keywords: qlt, 1st-qtr, visudyne, sales, up, canada, inc
Article | 21 April 2003
Canada's QLT Inc has reported that its alliance partner, Novartis,announced global Visudyne (verteporfin) sales of approximately $82.1
million for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 2003
14 April 2003
24 May 2013
© 2013 thepharmaletter.com